IMST for Coronary Heart Disease
(BREATHE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a breathing exercise called inspiratory muscle strength training (IMST) to determine if it can aid individuals with coronary artery disease (CAD) by enhancing blood flow to the heart. Researchers will compare high-intensity and low-intensity IMST to identify which is more effective. Individuals stable on their medications for at least a month and capable of performing breathing exercises may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance heart health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications, but you must have had no changes in your medications for the past month to participate.
What prior data suggests that high-intensity IMST is safe for patients with coronary artery disease?
Research shows that high-intensity inspiratory muscle training (IMST) is generally safe and well-tolerated. Studies have found that it strengthens and improves the endurance of breathing muscles without causing serious side effects. For individuals with heart conditions, such as coronary artery disease, this training has improved breathing.
While studies do not report major negative effects, this training is often used alongside other heart treatments. This indicates it is safe enough to be part of a larger treatment plan for heart patients. Therefore, for those considering joining a trial for high-intensity IMST, research supports its safety in enhancing heart and lung function.12345Why are researchers excited about this trial?
Researchers are excited about IMST (Inspiratory Muscle Strength Training) for coronary heart disease because it offers a novel, non-pharmacological approach to improving heart health. Unlike standard treatments that often rely on medications or invasive procedures, IMST focuses on strengthening the respiratory muscles, potentially enhancing cardiovascular function with just a small, portable device. This method could offer a low-cost, accessible way for patients to manage their condition with fewer side effects and a more convenient treatment regimen. High-intensity IMST, in particular, is being explored for its potential to deliver significant benefits in a shorter time compared to traditional methods.
What evidence suggests that this trial's treatments could be effective for coronary artery disease?
Research has shown that high-intensity inspiratory muscle strength training (IMST), which participants in this trial may receive, can improve heart health. In earlier studies, high-intensity IMST strengthened breathing muscles and increased their endurance, while also helping the heart manage stress more effectively. Although both high and low-intensity IMST, which this trial compares, have proven beneficial, high-intensity IMST is particularly noted for its potential to enhance heart health. Inspiratory muscle training is considered an effective method for assisting individuals with heart problems.12467
Who Is on the Research Team?
Benjamin Chow, MD
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
This trial is for adults over 18 who can do respiratory exercise tests and are stable, including no medication changes in the last month. They must be referred to PET at the University of Ottawa Heart Institute with coronary artery disease but without severe non-cardiac issues, unstable angina, severe valvular heart disease, hypertrophic cardiomyopathy or COPD.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete 8 weeks of high-intensity or low-intensity inspiratory muscle strength training (IMST)
Follow-up
Participants are monitored for changes in coronary blood flow and other health metrics after IMST
What Are the Treatments Tested in This Trial?
Interventions
- High-intensity IMST
- Low-intensity IMST
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor